Crossmark

(2S,4R)-4-[18F]Fluoroglutamine as a PET Indicator for Bone Marrow Metabolism Dysfunctional: from Animal Experiments to Clinical Application

Crossref DOI link: https://doi.org/10.1007/s11307-019-01319-4

Published Online: 2019-02-21

Published Print: 2019-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Hua

Liu, Fei

Zhang, Yan

Yang, Jianhua

Xu, Xiaoxia

Guo, Xiaoyi

Liu, Teli

Li, Nan

Zhu, Lin

Kung, Hank F.

Yang, Zhi
Funding

Funding for this research was provided by:

Beijing Natural Science Foundation Key Program (7171002)

National Natural Science Foundation of China (81671733, 81571705)

National Natural Science Foundation of China (81501519)
License Information

Text and Data Mining valid from 2019-02-21
More Information

Article History

First Online: 21 February 2019

Compliance with Ethical Standards

:

: Inclusion of human participants and use of human data and human tissue in this study were approved by the Ethics Committee of Peking University Cancer Hospital. The use of animals in this study was approved by the animal research committee in Peking University Cancer Hospital. This clinical study was approved by the Institutional Review Board of Peking University Cancer Hospital (No. 2017KT38). Enrollment begins from 18 August 2017 to 30 December 2018. URL: not applicable.

: The authors declare that they have no conflict of interest.

: Not applicable.